Imovane vs. Lunesta
Monday, October 16th, 2006The main difference between all of them [eszopiclone, zaleplon, zolpidem], except for half-life, may be that the manufacturer of Lunesta sponsored a 6-month trial and submitted the results to the FDA, while the other 2 manufacturers did not.